Position in MNPR
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$518,596
+$211,718 QoQ
Shares Held
5,601
0.0% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#49
of 95 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MNPR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GERBER, LLC holds $523,257 across 2 Biotechnology names. MNPR ranks #1 (99.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MNPR |
Monopar Therapeutics
This page
|
5,601 | $518,596 | |
| 2 | GOSS |
Gossamer Bio, Inc.
|
28,249 | $4,661 |
All Filings in MNPR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $518,596 | 5,601 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $306,878 | 5,601 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $365,745 | 5,601 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $457,433 | 5,601 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $200,403 | 5,601 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $203,932 | 5,601 | Shares | Sole | 2025-04-23 | |
| 2024-06-30 | $20,443 | 28,005 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $19,071 | 28,005 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $9,521 | 28,005 | Shares | Sole | 2024-03-05 | |
| No filing history on record for this holder in this stock. | ||||||